Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Arrhythmias Wrongfully Linked to TAVR?

Continuous electrocardiographic monitoring pre-transcatheter aortic valve replacement (TAVR) detected arrhythmic events in almost half the patients analyzed in this study (which will be published soon in JACC Interventions). A fourth of these patients needed urgent therapeutic actions before the procedure.

TAVI bajo riesgo

Previous conduction disorders—particularly, right bundle branch block and chronic renal insufficiency—were linked to a higher risk of arrhythmias.

These previously undiagnosed arrhythmias are too frequent and, as such, we could say that many have been “wrongfully” linked to TAVR—diagnosis is made during post-implantation monitoring, the arrhythmia is considered new and is registered as an event linked to the procedure, when in fact the issue had always been present.

The novelty of this research is using continuous electrocardiographic monitoring to detect the incidence and type of arrhythmic events in candidates for TAVR. It also provides insight into the impact of therapeutic changes secondary to the detection of these unknown arrhythmias.


Read also: High Mortality Rates for Redo Surgery After TAVR.


This was a prospective study including 106 patients with severe aortic stenosis and no prior pacemaker implantation who were screened for TAVR. A prolonged (1 week) continuous electrocardiographic monitoring was conducted within the 3 months leading to the procedure.

Arrhythmic events were detected in 48.1% of patients, and 27.5% of them required treatment.

Atrial fibrillation and tachycardia were detected in 10.1% of subjects, while nonsustained ventricular arrhythmias were detected in 29.2% of patients. Significant bradyarrhythmias were observed in 20.8% of patients, leading to changes in their medication or permanent pacemaker implantation.


Read also: Post TAVR Regression of Ventricular Mass.


The detection of bradyarrhythmias increased up to 30% among patients with pre-existing first-degree atrioventricular block, and up to 47% in those with right bundle branch block.

Chronic renal failure, higher valve calcification, and ventricular dysfunction determined (or tended to determine) an increased risk of undiagnosed arrhythmias.

Post-TAVR events occurred in 22.1% of the population. Previous continuous monitoring expedited diagnosis and decision-making in one-third of patients.

Original Title: Prolonged Continuous Electrocardiographic Monitoring Prior to Transcatheter Aortic Valve Replacement. The PARE Study.

Reference: Lluis Asmarats et al. J Am Coll Cardiol Intv 2020, article in press. https://doi.org/10.1016/j.jcin.2020.03.031.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...

Beyond TAVI: Cardiac Rehabilitation as a Determinant of Clinical Outcomes

Aortic stenosis is an increasingly prevalent condition associated with population aging, with a prevalence of approximately 3.4% in individuals over 75 years of age...

Comparative outcomes between transaxillary approach and thoracotomy-based approaches in TAVI with alternative access

TAVI has become the standard treatment for high-risk aortic stenosis. When transfemoral access is not feasible (approximately 10–15%), alternative approaches are used: transaxillary (subclavian...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...

SCAI 2026 | SELUTION DeNovo subanalysis: Use of sirolimus-eluting balloon in acute coronary syndrome

Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation remains the predominant strategy in the setting of acute coronary syndrome (ACS). However, in recent...